North Kansas City, Mo.-based Cerner (NASDAQ:CERN) is making its second small acquisition in less than a month.
Cerner didn't disclose financial details on the transaction, saying only that it "is not expected to have a material impact on Cerner's 2013 financial results." Regardless, shareholders dinged Cerner stock by 1.8%, which fell to $91.12 in Monday trading.
Fool contributor Rich Smith and The Motley Fool have no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Why Shares of Cerner Corp. Are Down Today
Third-quarter results fell short of expectations, but the company sees business picking back up in the fourth quarter.
Cerner Corporation Unimpressive in 3rd Quarter, but Expects Better Days Ahead
The healthcare technology company reports so-so growth and lower bookings than expected.
Cerner Corporation Meets Expectations in Second Quarter With Solid Recurring Revenue
The healthcare technology company did what it needed to do in the second quarter.